SAVARA INC (SVRA)
US8051111016 - Common Stock
SVRA Makes Notable Cross Below Critical Moving Average
Savara Announces New Employment Inducement Grant
SVRA Stock Earnings: Savara Beats EPS for Q4 2023
SVRA stock results show that Savara beat analyst estimates for earnings per share the fourth quarter of 2023.
SVRA Stock Earnings: Savara Beats EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Savara (NASDAQ:SVRA) just reported results for the fourth quarter of 2023.Savar...
Savara Reports Fourth Quarter/Year-End 2023 Financial Results and Provides Business Update
Savara to Present at the Barclays 26th Annual Global Healthcare Conference
Commit To Purchase Savara At $2.50, Earn 8% Annualized Using Options
JMP starts Savara at buy, cites market potential for lung disease drug (NASDAQ:SVRA)
JMP has started coverage of Savara (SVRA) with a buy rating, citing the market potential of its drug candidate molgramostim for the treatment of autoimmune pulm
Savara Announces New Employment Inducement Grant
Savara to Present at Two Upcoming Healthcare Conferences
Savara added to Nasdaq Biotechnology Index (NASDAQ:SVRA)
Savara has been added to the Nasdaq Biotech Index, boosting its presence in the biotechnology industry and potentially impacting its stock performance.
Savara Added to the NASDAQ Biotechnology Index
Savara Announces New Employment Inducement Grant
Savara to Present at the Piper Sandler 35th Annual Healthcare Conference
Commit To Buy Savara At $2.50, Earn 12% Annualized Using Options
Savara Reports Third Quarter Financial Results and Provides Business Update
Savara to Present at the Jefferies London Healthcare Conference
Savara Announces New Employment Inducement Grant
3 Penny Stocks to Provide 1,000% Returns Over the Next Decade
Consider three intriguing penny stocks for investors looking to add a bit more risk to their portfolio in times like these.
The 3 Best Penny Stocks to Buy Now: September 2023
When all the focus lies on the largest names of the economy, these best penny stocks to buy offer a great risk/reward ratio.
Savara to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Savara GAAP EPS of -$0.07 beats by $0.01 (NASDAQ:SVRA)
Savara press release (SVRA): Q2 GAAP EPS of -$0.07 beats by $0.01.$105M in Cash and Cash Equivalents at the End of 2Q 2023
Savara Reports Second Quarter Financial Results and Provides Business Update
Savara Announces New Employment Inducement Grant
Commit To Purchase Savara At $2.50, Earn 13.9% Annualized Using Options
Savara prices $80M common stock and pre-funded warrants offering (NASDAQ:SVRA)
Savara (SVRA) prices an underwritten offering of 21M common shares at $3.00 per share and 5.66M pre-funded warrants to purchase common stock at a price of $2.999 per pre-funded warrant...
Savara Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Savara Added to Russell 3000® Index
Savara to Present at the Jefferies Healthcare Conference
Insiders Seeing Green With SVRA At New 52-Week High